2
20 – 22 June 2017 SNIEC Shanghai Organised by: CPhI, the industry’s best way to grow your business in China! Why China? Co-located with: For further details, please contact: Martin Cheung, Sales Manager [email protected] +31 (0)20 708 1735 1 2 3 4 5 6 China is the world’s largest producer of pharma ingredients, critical intermediates and excipients and the world’s second largest pharma market The Chinese pharma market has huge opportunities to grow, covering 40% of global APIs production Chinese manufacturers are deepening ties with global pharma markets by investing in APIs, generics, biologics, biosimilars, finished formulation and packaging The government is increasing investment in healthcare and R&D China is excelling in the pharmaceutical regulatory review and approval system and making great efforts to eliminate the drug application backlog within 2-3 years China presents great opportunities for innovative products and technologies, and collaboration between international and domestic pharmaceutical companies

Co-located withubmasiafiles.com/files/sinoexpo/cphi/CPhI_China_2017_Brochure.pdf · The Chinese pharma market has huge opportunities to grow, covering 40% of global APIs production

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Co-located withubmasiafiles.com/files/sinoexpo/cphi/CPhI_China_2017_Brochure.pdf · The Chinese pharma market has huge opportunities to grow, covering 40% of global APIs production

20 – 22 June 2017 • SNIEC • Shanghai

Organised by:

CPhI, the industry’s best way to grow your business in China! Why China?

Co-located with:

For further details, please contact:Martin Cheung, Sales Manager

[email protected] +31 (0)20 708 1735

1 2 3

4 5 6

China is the world’s largest producer of pharma ingredients,

critical intermediates and excipients and the world’s second

largest pharma market

The Chinese pharma market has huge opportunities to grow,

covering 40% of global APIs production

Chinese manufacturers are deepening ties with global pharma

markets by investing in APIs, generics, biologics, biosimilars,

finished formulation and packaging

The government is increasing investment in healthcare and R&D

China is excelling in the pharmaceutical regulatory review and approval system and making great efforts to eliminate the drug

application backlog within 2-3 years

China presents great opportunities for innovative products and

technologies, and collaboration between international and domestic pharmaceutical

companies

Page 2: Co-located withubmasiafiles.com/files/sinoexpo/cphi/CPhI_China_2017_Brochure.pdf · The Chinese pharma market has huge opportunities to grow, covering 40% of global APIs production

For further details, please contact:Martin Cheung, Sales Manager

[email protected] +31 (0)20 708 1735

CPhI China is the most comprehensive and pure pharma-focused event to do international pharma business in China and wider Asian region!

APICRO / CMOBiopharmaceuticalsNatural ExtractsFine chemicals and intermediatesPharma machinery

120 countries35,000 attendees

Packaging equipment & materialLaboratory equipmentEnvironmental protection and cleanPharma logistics

Co-located with:Hi Asia and Fi Asia – China, for food ingredients, machinery, nutraceutical & health products

Top 10 Visitor Countries

CPhI China, one stop shop platform gathering:

Germany

India

Italy

USA &Canada

Japan

China

Russia

Brazil

Hong Kong

Visitors’ Job Title

20%President/Chairman/Director/General Manager

19%Manager/

Project Managers/Department

heads

15%Purchasing Manager

11%R&D

Manager

Other:8% Researcher7% Technical/

Engineer6% Sales Manager5% Marketing

Manager3% Logistic

Manager2% Product

Manager2% Quality Control

Manager2% Other

BOOK YOUR STAND

“The past 15 years I have seen CPhI grow bigger and bigger in scale. Chinese raw material suppliers have become more and more professional. More companies have secured authentication from the US, EU and Japan, as more foreign customers choose to join the CPhI exhibition.”

Yaping ShenVice President Jiangsu Hengrui Medicine Co., Ltd.

For more information:gotocphi.com/cphichina2017

Join the conversation@cphiww #cphichina